Post Market Registry Study of the AeriSeal System

Status Terminated

Clinical Trial Summary

- Obtain and analyze medical record data on patients with advanced emphysema who receive treatment with the AeriSeal System to better understand safety and effectiveness in the post-market setting;

- Provide participating physicians access to specified data sets for the purpose of generating scientific manuscripts about the effects of AeriSeal System treatment.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01520064
Study type	Observational [Patient Registry]
Source	Aeris Therapeutics
Contact
Status	Terminated
Phase	N/A
Start date	February 2012
Completion date	November 2013

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00995852` - Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study	Phase 2/Phase 3
Completed	`NCT01860898` - A Phase I Study of iPS Cell Generation From Patients With COPD	N/A
Completed	`NCT00123422` - Innovation in Pulmonary Rehabilitation	N/A
Recruiting	`NCT02879331` - Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils	N/A
Completed	`NCT01507415` - Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?	N/A
Completed	`NCT01051258` - AeriSeal System for Lung Volume Reduction	Phase 1/Phase 2
Completed	`NCT00680056` - Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients	Phase 4
Completed	`NCT01872624` - Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema	N/A
Completed	`NCT01110252` - Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease	N/A
Completed	`NCT00517998` - Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study	Phase 1
Terminated	`NCT00205920` - Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation	Phase 2
Withdrawn	`NCT01849159` - Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema	Phase 1/Phase 2
Completed	`NCT01869205` - The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients	Phase 3
Terminated	`NCT01320566` - A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema	Phase 2/Phase 3
Completed	`NCT00683722` - PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)	Phase 2
Active, not recruiting	`NCT04465461` - Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion	N/A
Completed	`NCT04012359` - Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax
Recruiting	`NCT04918706` - Allogeneic MSC Treatment for Pulmonary Emphysema	Phase 2
Terminated	`NCT01449292` - Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)	Phase 3
Completed	`NCT00347659` - US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study	Phase 1